Osinski C, Le Glau L, Poitou C, de Toro-Martin J, Genser L, Fradet M, et al
This baseline serves two purposes
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates genetic predispositions in GLP-1 receptor pathways (GLP1R rs6923761 variant), metabolic regulation (FTO rs9939609), and appetite signaling (MC4R rs17782313) that may help provide context for understanding individual response patterns to GLP-1 medications
The genetic test does not predict exact medication response or guarantee outcomes
Once this vial has been open, it has been exposed to air and germs
Other studies have evaluated acinar-ductal metaplasia (ADM) and PanIN formation, a precancerous lesion